• 13th International Wokshop on CLL (16-18th October 2009)
• Barcelona

Further details to follow

For further information please visit http://www.iwcll.org/

• UK CLL Forum Autumn Meeting (Thursday 24th September 2009)
• Royal College of Pathologists, 2 Carlton House Terrace, London
• Programme

For further information please contact email cll@hartleytaylor.co.uk or telephone 01844 275650

• UK CLL Forum Annual Scientific Day - The Genetics of CLL (Thursday 26th March 2009)
• 28 Portland Place, London W1B 1DE

Download programme.

For further information please contact email cll@hartleytaylor.co.uk or telephone 01844 275650

• UK CLL Forum Clinical Science Day (29th April 2008)
• Jarvis Lecture Theatre, RIBA, 66 Portland Place, London
- Programme

Proliferation in CLL
Nicholas Chiorazzi
New York, USA

CLL - who are the collaborators?
Andrea Buggins
King's College, London

The aLb2 defect of CLL cells
Kathy Till
Liverpool

CD38 in CLL
Silvia Deaglio
Turin, Italy

The leukaemic microenvironment as a target for therapy in CLL
Stephen Devereux
King's College, London

Targeting NF-kB as a therapeutic strategy in CLL
Saman Hewamana
Cardiff

UK CLL Clinical Trials update
Peter Hillmen
Leeds

Local CLL Biobanking (Part 1 | Part 2)
Aneela Majid
Leicester

UK CLL Trials Biobank
Andy Pettitt
Liverpool

• UK CLL Bio-bank Workshop (4th Dec 2007)
-LRF Building, 39 40 Eagle Street, London WC1R 4TH

• UK CLL Annual Education Day (19th Nov 2007)
- Rutherford Lecture Theatre, Institute of Physics, 76 Portland Place, London
- Programme

Overview of prognostic factors
Ulrich Jaeger, Vienna

Immunogenetic clues to the origin and behaviour of CLL
Freda Stevenson, Southampton

Chromosomal abnormalities
Thorsten Zenz, Ulm

CD38/ZAP-70 and immunophenotype
Andy Rawstron, Leeds

Serum factors
David Oscier, Bournemouth

UK CLL Clinical Trials Update
Peter Hillmen, Leeds

Prognostic factors as a guide to therapy
Peter Hillmen, Leeds

Prognostic potential of population-based studies
Martin Dyer, Leicester

Prognostic potential of gene expression profiling
Robin Foa, Rome


2007 Catovsky Prize

Fiona Bennett, Leeds
Outcome for patients with Monoclonal B-cell Lymphocytosis (MBL), a pre-cursor state for Chronic Lymphocytic Leukaemia (CLL)

Thet Thet Lin, Cardiff
CD38+ sub-populations have increased proliferative activity but similar telomere lengths and hTERT expression when compared with CD38- sub-populations derived from the same CLL patient

Aneela Majid, Leicester
BCL2 expression in chronic lymphocytic leukemia (CLL): lack of association with the BCL2 -938A>C promoter single nucleotide polymorphism (SNP)

Elaine Willmore, Newcastle
DNA-dependent protein kinase overexpression is associated with poor prognosis B CLL: a new therapeutic target

Anton Parker, Bournmouth
ZAP70 Methylation as a Prognostic Marker in CLL

• XII iwCLL 2007 (14th-16th Sept 2007)
• London UK
• The biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is now established in the calendar of premier scientific meetings. The iwCLL meeting in 2007 will focus on the basic science and clinical management of CLL.
• www.iwcll.org

• UK CLL Forum Clinical Science Day (23rd May 2007)
- RIBA Lecture Theatre, 66 Portland Place, London
- Programme

CLL cells and antigen presentation
Dr Robert Barker
University of Aberdeen

Role of antigen in the development of CLL
Dr Richard Rosenquist Brandell
Uppsala University, Sweden

Role of antigen in the perpetuation of CLL
Dr David Allsup
Hull Royal Infirmary

T-cell abnormalties in CLL
Dr Paul Moss
University of Birmingham

The CLL Support Association
Mr Howard Pearce
CLLSA